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Methods: Mild cognitive impairment (MCI) patients (n 5 58) and their informants (n 5 51)
completed the Memory Assessment Clinics self- (MAC-S) and family (MAC-F)-rating scales as a
measure of subjective memory. Repeatable Battery for the Assessment of Neuropsychological Status
(RBANS) Immediate and DelayedMemory indices were used as objective measures of memory and a
subset of MCI participants also underwent magnetic resonance imaging, which was used to measure
MTL volume.
Results: Patients reported greater difficulty with semantically based information (e.g., word and
name recall) relative to informant report. However, the severity of these self-reports was unrelated
to objective memory performance and only a single MAC-S scale was related to amygdalar volume.
Conversely, several MAC-F indices were related to the RBANSDelayedMemory index and to amyg-
dalar and hippocampal volumes.Measures of executive functioning were associated withMAC-S fre-
quency scales but not any MAC-F scale.
Discussion: The results of this study suggest that, in those who are cognitively symptomatic, the fre-
quency of self-reported subjective memory difficulty may reflect executive dysfunction but holds lit-
tle value for verifying memory impairment. Conversely, informant report provides meaningful
information about actual memory deficits in those with MCI.
Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords: Aging; Diagnosis; Memory complaints; Dementia; Alzheimer’s disease1. Introduction
Mild cognitive impairment (MCI) describes an interme-
diate state between normal aging and dementia and is char-
acterized by significant cognitive deficits, especially in the
areas of learning and memory. Specifically, MCI requires
(1) subjective memory complaints, preferably corroborated
by an informant, (2) objective memory decline, and (3) author. Tel.: 11-734-763-9259; Fax: 11-734-936-
ampste@med.umich.edu
16/j.dadm.2015.03.002
by Elsevier Inc. on behalf of the Alzheimer’s Association
licenses/by-nc-nd/4.0/).general preservation of everyday functioning [1,2].
Additionally, brain atrophy within the medial temporal
lobes (MTL) has been associated with objective learning
and memory deficits in MCI [3,4]. The current report
addresses a knowledge gap about self- and informant-
report of memory complaints and their relationship with
objective memory performance and MTL volumes.
Subjective memory complaints help to establish a decline
in functioning relative to premorbid status, and existing ev-
idence suggests that the presence of such complaints may be
a harbinger of subsequent cognitive decline [5–7]. In
addition, studies have reported similar MTL volumes (and. This is an open access article under the CC BY-NC-ND license (http://
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adults with subjective memory complaints [8]. An important
caveat is that these relationships generally appear limited to
“cognitively intact” older adults (i.e., those whose objective
memory test performances fall within normal limits). A
meta-analysis [9] and a review of longitudinal studies [5] re-
vealed inconsistent evidence for the value of subjective
memory complaints in those with objective memory impair-
ment (i.e., MCI). Informant-reported memory impairment
may hold diagnostic value as it has previously been shown
to reflect objective memory test impairment [10–12].
Conversely, some studies have found a relationship
between subjective memory complaints and objective test
performance [5,13], whereas other studies have not
[10,14]. Such discrepant results may arise from the
presence or absence of anosognosia, which is a common
feature of Alzheimer’s disease (AD) that has been variably
reported in MCI [15–17]. It is important to note that such
awareness of deficit requires the ability to monitor and
evaluate one’s performance in the moment, which
literature suggests requires intact executive abilities and
associated prefrontal-parietal networks [e.g., 18,19]. Of
course, being able to report the nature and/or severity of
cognitive impairment requires an accurate memory for the
episodes of failure, which certainly relies on the MTL
memory system. Thus, MCI patients may experience
difficulty due to one or both of these aspects of awareness.
Another reason for the discrepant findings about the value
of self-reported complaints is that a range of measures have
been used, most of which dichotomize participants based on
a single question (i.e., present vs. absent) [5]. Recently,
Buckley et al. [14] examined the relationship between sub-
jectivememory, affect, and biomarkers of AD in a large sam-
ple of healthy controls and MCI patients who were enrolled
in the Australian Imaging Biomarkers and Lifestyle study of
Aging. Importantly, this study used the memory assessment
clinics questionnaire (MAC-Q [20]), which is a brief mea-
sure that rates the severity of subjective memory complaints
along a continuum. The results demonstrated that complaint
severity was unrelated to objectivememory test performance
or to any biomarkers of AD (gray matter, white matter, or
hippocampal volumes; amyloid burden) in either group.
Similarly, another recent study found that informant report
of overall cognitive impairment in MCI patients was more
related to biomarkers of AD than was self-report [12; though
see 13 for positive findings]. It is possible that the brevity of
the measures used in these studies limited the detection of
meaningful relationships in the MCI patients, in which
case a more comprehensive measure that assesses perceived
difficulty across different situations/contexts will be more
reflective of objective impairment.
The current study used the full MAC self-rating scale
(MAC-S) and family-rating (MAC-F) questionnaires, which
provide continuous measures of functioning across several
ecologically relevant contexts, to assess subjective memory
complaints in those previously diagnosed with MCI. Thesesubjective ratings were correlated with objective memory
test performances (via the memory indices from the Repeat-
able Battery for the Assessment of Neuropsychological Sta-
tus—RBANS), measures of executive functioning, andMTL
volumes. Thus, this study allowed us to directly compare the
utility of self- vs. informant-report of memory complaints
while at the same time examining potential biological expla-
nations for any observed differences.2. Methods
2.1. Participants
A total of 58 participants, diagnosed with MCI according
to Petersen’s criteria [2], were recruited from the Emory
University Alzheimer’s Disease Research Center and sur-
rounding community as part of a larger, multisession study
on cognitive rehabilitation. Each patient had been diagnosed
with MCI at a consensus conference using all relevant clin-
ical data (e.g., laboratory findings, neuroimaging, neuropsy-
chological testing). Participants were then referred to our
study and, after providing written informed consent,
completed a brief neuropsychological protocol that included
both subjective and objective measures of memory func-
tioning (see Table 1). This protocol was developed to mini-
mize overlap with the tests used during the diagnostic
process. For example, we used the RBANS as a brief, yet
relatively comprehensive, measure of cognitive functioning
(especially for learning and memory) given evidence of its
sensitivity to MCI [21] and AD [22]. These results allowed
us to ensure persistent cognitive (especially memory) defi-
cits at the time of study enrolment. Informant-based infor-
mation was obtained for 51 of these participants using the
MAC-Family (MAC-F) questionnaire during this screening
session. Informants were typically spouses or other family
members and all lived and/or interacted with the patient
multiple times per week. All neuropsychological and neuro-
imaging data (see later) included in this study were both
independent of those used for the clinical diagnosis and
obtained before cognitive rehabilitation was provided.
General exclusion criteria included a history of neuro-
logic injury or disease (e.g., stroke, moderate or severe trau-
matic brain injury, and epilepsy), psychiatric disorders
(e.g., severe depression, bipolar disorder schizophrenia),
and current or past alcohol or drug abuse/dependence. The
Institutional Review board of Emory University approved
the study procedures.
2.2. MAC—self and family-rating scale
The MAC-S consists of 21 items that assess one’s
perceived functioning (i.e., ability) and that are grouped
into five memory areas (Remote, Numeric, Everyday,
Semantic, and Spatial) [23]. It also includes another 24
items that assess the frequency of memory concerns and
are also grouped into five scales (Semantic, Concentration,
Everyday, Forgetfulness, and Facial). There are four global
Table 1
Demographics, neuropsychological measures, and brain volumes for
patients with MCI
MCI (n 5 58)
Gender Number of participants
Male 33
Female 25
Ethnicity Number of participants
Caucasian 37
African American 19
Latino 2
M (SD)
Age (years) 71.69 (8.28)
Education (years) 15.86 (2.79)
MMSE 27.47 (2.19)
WAIS-III Information Subset 12.14 (2.52)
WTAR-Reading Standard Score
VIQ 109.22 (13.05)
PIQ 106.17 (9.79)
FSIQ 108.10 (13.19)
Trails A (T-score) 47.43 (10.32)
Trails B (T-score) 48.36 (11.24)
Emory WCSTy
# Strategies identified 2.63 (0.59) (WNL)
# Sorts completed 3.37 (1.70) (21 SD)
# Perseverative errors 5.93 (6.07) (WNL)
# Set loss errors 1.63 (1.72) (21 SD)
WMS/KBNA (percent correct)
Auto index—accuracy 98.25 (3.01)
Nonauto index—accuracy 84.44 (16.66)
GDS 1.69 (1.76)
FAQ 3.41 (4.64)
RBANS indices (std. score)
Immediate memory 87.48 (14.55)
Delayed memory 80.09 (18.96)
Visuoconstructional 95.60 (16.74)
Language 92.72 (15.02)
Attention 96.48 (14.58)
Total score 87.52 (11.78)
Brain volumes (% of total ICV)*
Inferior lateral ventricle 0.20 (0.09)
Hippocampus 0.47 (0.07)
Amygdala 0.21 (0.04)
Abbreviations: MCI, mild cognitive impairment; MMSE, Mini-Mental
Status Examination; WAIS-III, Weschler Adult Intelligence Scale-III;
WTAR,Weschler Test of Adult Reading; VQI, Verbal Intelligence Quotient;
PIQ, Performance Intelligence Quotient; FSIQ, Full Scale Intelligence Quo-
tient; EmoryWCST, Emory version of theWisconsin Card Sorting Test; SD,
standard deviation; WMS/KBNA, Weschler Memory Scale/Kaplan Baycr-
est Neurocognitive Assessment; GDS, Geriatric Depression Scale; FAQ,
Functional Assessment Questionnaire; RBANS, Repeatable Battery for
the Assessment of Neuropsychological Status; ICV, intracranial volume.
*Brain volumes provided by NeuroQuant.
yEmory WCST performance ranges are based on internally developed
normative data (WNL 5 within normal limits).
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concern and that form the Global Memory scale. The
MAC-F uses the same format and number of items but is
completed by an informant. Both the MAC-S and -F use a
5-point Likert scale to evaluate the severity of perceived
impairment, where low scores represent difficulty
(15 very poor; 55 very good). Ratings for each of the state-
ments are summed for the five ability and five frequencyscales. Totals for each scale are added to provide the total
ability and total frequency, all ofwhich are then z-normalized
[24]. Low z-scores indicate poor ability, frequent memory
concerns, and a worse overall rating of their current memory,
whereas a higher score indicates the opposite.
2.3. Structural magnetic resonance imaging and
volumetric measurements
A total of 40 MCI patients underwent high-resolution
anatomic magnetic resonance imaging (MRI) scanning as
part of a recently completed cognitive rehabilitation study,
the results of which will be reported elsewhere. Participants
were scanned an average of 47 days (SD 5 35.5) after
completing the neuropsychological and subjective measures
described previously. All scans were performed using a
Siemens Trio 3T MRI Scanner (Siemens Medical Solutions,
Malvern, PA) with a 12-channel head coil. High-resolution
anatomic images were acquired using a three-dimensional
magnetization prepared rapid acquisition gradient echo
(MPRAGE) sequence (repetition time [TR] 2300 ms, echo
time [TE] 3.9 ms, flip angle [FA] 8) with 176, 1 mm thick,
sagittal slices (field ofview [FOV] 256mm, in-plane resolution
1! 1 mm, in-plane matrix 256! 256). All data in this report
were collected before any cognitive rehabilitation. A senior
MR technologist visually inspected all data at the timeofacqui-
sition; suboptimal scans were repeated to ensure usable data.
Volumetric data were obtained via NeuroQuant. Details
of the segmentation process can be found elsewhere [3,25].
Briefly, NeuroQuant performs two quality control checks
that (1) ensure that data adhere to the automatic segmen-
tation specifications using a measurement index that
quantifies the deviation between the target brain and a
normalized anatomic atlas; (2) corrects for gradient
nonlinearities and field inhomogeneities (using the same
methods as the Alzheimer’s Disease Neuroimaging
Initiative [ADNI]). Skull stripping and nonlinear registration
to a probabilistic atlas follow. During segmentation, each
voxel is given a neuroanatomical label based on its location
within the atlas and then iteratively checked to maximize
the probability that it belongs to the labeled structure. A
report is then generated that provides the volumes of brain
structures as a percent of intracranial volume (ICV), which
accounts for head size and allows for interindividual
comparisons. NeuroQuant provides the volumes of three
MTL regions: the hippocampus, inferior lateral ventricles,
and the amygdala. Total volumes for these structures were
calculated by combining the left and right hemisphere
volumes (all values are in percent of ICV).
2.4. Statistical analyses
All analyses were performed using IBM SPSS Statistics
21. Between group comparisons used independent t-tests.
We performed correlational analyses (Pearson’s r) to deter-
mine relationships between subjective complaints (MAC-S
or -F as appropriate), objective memory test performances
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measures of executive functioning (Trails A, Trails B, and
select aspects of the Emory version of the Wisconsin Card
Sorting Test), and MTL volumes. Self- and informant-
reports of subjective impairment were considered separately.
For all analyses, we used the false discovery rate (FDR) to
correct for multiple comparisons because it minimizes
both type I and type II error [26].3. Results
3.1. Self-report (MAC-S) versus informant-report (MAC-
F)
Patients reported significantly more memory difficulty on
the semantic ability (e.g., remembering the meaning of both
familiar and rarely used words) and frequency indices and
the facial frequency scale relative to informants (Table 2).
Although it did not survive FDR correction, informants
tended to rate everyday memory functioning worse than
did patients. As seen in the table, however, mean ratings
for nearly all scales fell within 1 standard deviation of the
mean for both patients and informants.
3.2. Self-report (MAC-S) findings
There were no significant correlations between any sub-
jective scale and objective memory index (Table 3). Howev-
er, amygdalar volume was inversely related to the frequency
of General Forgetfulness scale of the MAC-S. Regarding
measures of executive functioning, the number of set loss er-
rors on the Emory version of theWCSTwas inversely related
to both the Frequency of Concentration and Forgetfulness
scales. The relationship between MAC-S scales and severalTable 2
Between group differences in subjective memory functioning (z-scores) and
effect sizes (Cohen’s d)
MAC-S
(z-scores)
(n 5 58),
M (SD)
MAC-F
(z-scores)
(n 5 51),
M (SD) t(107) P Cohen’s d
Ability
Remote 0.13 (0.79) 0.08 (1.03) 0.27 .786 0.054
Numeric 0.17 (0.97) 0.41 (1.20) 1.17 .244 0.220
Everyday 0.25 (0.84) 20.38 (2.08) 2.11 .038 0.397
Semantic 20.03 (0.67) 0.35 (0.97) 2.41 .018* 0.456
Spatial 20.09 (0.94) 20.03 (1.24) 0.30 .769 0.055
Total 20.64 (0.74) 20.61 (1.09) 0.20 .843 0.032
Frequency
Semantic 20.80 (0.80) 20.36 (0.85) 2.76 .007* 0.533
Concentration 20.02 (0.93) 0.37 (1.20) 1.95 .053 0.363
Everyday 0.28 (0.94) 0.24 (1.03) 0.23 .818 0.041
Forgetfulness 20.18 (0.92) 20.10 (1.02) 0.46 .650 0.082
Facial 0.18 (0.83) 0.63 (1.01) 2.55 .012* 0.487
Total 21.22 (0.76) 20.91 (0.89) 2.01 .047 0.375
Abbreviations: MAC-S, Memory Assessment Clinics self-rating scale;
MAC-F, Memory Assessment Clinics family-rating scale; SD, standard de-
viation.
*Survives false discovery rate correction threshold of P  .027.other measures of theWCSTwas below the P, .05 level but
failed to survive FDR correction.
3.3. Informant-report (MAC-F) findings
The MAC-F Semantic, Spatial, and Total ability scales
were related to the RBANS Delayed Memory Index
(Table 4). Amygdalar volumes were related to MAC-F
Remote, Numeric, Everyday, Spatial, and Total ability
scales, and, frequency of Semantic and Facial occurrence
scales. Hippocampal volume was related to the ability to
remember numeric information. Measures of executive
functioning were unrelated to any of the MAC-F scales.
4. Discussion
This study examined the relationship between subjective
memory complaints, as measured by the MAC-S and MAC-
F, objective memory test performance, measures of execu-
tive functioning, and MTL volumes in patients diagnosed
with MCI. Consistent with a common clinical presentation,
we found that patients reported greater difficulty with as-
pects of semantic (e.g., meanings of words) and episodic
memory (e.g., recall of recently learned information) and
also noticed the frequency of such difficulty (e.g., tip of
tongue recall of names or words) more often than did their
informants. These findings mirror frequent clinical com-
plaints and are notable because they can feasibly be thought
to impede social interactions.
In contrast to these data, however, our results add to other
studies in this area showing that self-reported memory com-
plaints are unrelated to actual memory test performance (i.e.,
objective memory impairment) in MCI patients [10–12,14].
These findings are consonant with the expected effects of
memory impairment and reduced MTL integrity: that
patients cannot accurately remember the severity or extent
of their memory troubles. Our data revealed an inverse
relationship between the volume of the amygdala and the
frequency of forgetful type errors. The role of the amygdala,
as opposed to the hippocampus, was somewhat unexpected
but may reflect an enhanced emotional component to the
perceived deficits that facilitates their recollection, at least
until its structural integrity surpasses some biological
threshold. Conversely, subjective complaints were associated
with several aspects of the WCST (albeit these often failed
to surpass the FDR correction threshold), typically on the
Frequency Scales of the MAC-S. Most notable were the find-
ings that patients who more frequently lost mental set during
the WCST reported greater impairment with the Concentra-
tion and Forgetfulness Scales and tended to report more diffi-
culty with memory in general (i.e., Total Ability and Total
Frequency Scales). These findings (1) reinforce the previously
noted distinction between executive and memory contribu-
tions to awareness of deficit, (2) indicate that MCI patients
aremore sensitive to the frequencywithwhich theyhavemem-
ory failures rather than their actual memory abilities, and (3)
suggest that the validity of subjective memory complaints
Table 3
Pearson correlations (P-value) between MAC-S scores, MTL volumes (in percent of total ICV), RBANS memory indices, and measures of executive functioning
MAC-S
Percent ICV (n 5 40) RBANS indices (n 5 58) Emory WCST (n 5 57)
HP ILV AMY IMI DMI Trails A Trails B # ID’d Sorts Persv Set loss
Ability to remember scales
Remote 0.088 (0.589) 0.093 (0.569) 20.097 (0.550) 20.097 (0.467) 0.079 (0.557) 0.033 (0.804) 20.203 (0.138) 0.054 (0.691) 0.161 (0.232) 0.003 (0.982) 20.248 (0.062)
Numeric 20.005 (0.977) 0.234 (0.146) 20.085 (0.602) 0.000 (0.998) 20.128 (0.339) 0.006 (0.966) 20.044 (0.749) 0.224 (0.094) 0.287 (0.030) 20.069 (0.609) 20.221 (0.099)
Everyday 20.071 (0.663) 0.236 (0.142) 20.298 (0.062) 20.106 (0.431) 20.006 (0.965) 0.009 (0.948) 20.002 (0.989) 0.185 (0.168) 0.090 (0.507) 0.124 (0.360) 20.251 (0.059)
Semantic 20.173 (0.286) 0.205 (0.204) 20.290 (0.070) 0.070 (0.601) 20.106 (0.428) 0.054 (0.688) 20.138 (0.316) 0.226 (0.090) 0.101 (0.454) 0.171 (0.205) 20.163 (0.224)
Spatial 0.173 (0.287) 0.037 (0.821) 20.068 (0.678) 20.024 (0.859) 0.062 (0.645) 0.146 (0.273) 0.183 (0.180) 20.040 (0.768) 0.107 (0.430) 0.043 (0.750) 20.123 (0.363)
Total 0.016 (0.921) 0.220 (0.173) 20.211 (0.192) 20.051 (0.705) 20.023 (0.865) 0.064 (0.635) 20.045 (0.744) 0.171 (0.204) 0.215 (0.108) 0.053 (0.694) 20.277 (0.037)
Frequency of occurrence scales
Semantic 20.146 (0.369) 0.296 (0.063) 20.199 (0.218) 20.056 (0.676) 20.245 (0.064) 20.006 (0.967) 20.152 (0.268) 0.170 (0.205) 0.105 (0.435) 0.103 (0.444) 20.128 (0.343)
Concen 0.024 (0.885) 0.042 (0.795) 20.251 (0.183) 0.145 (0.277) 20.074 (0.582) 0.105 (0.435) 20.077 (0.575) 0.267 (0.045) 0.149 (0.268) 0.216 (0.107) 20.326 (0.013)*
Everyday 20.076 (0.643) 0.267 (0.096) 20.289 (0.070) 20.119 (0.374) 20.281 (0.032) 20.226 (0.089) 20.241 (0.076) 0.057 (0.674) 0.056 (0.679) 0.223 (0.096) 20.192 (0.154)
Forgetful 20.204 (0.207) 0.138 (0.394) 20.473 (0.002)* 0.073 (0.588) 20.007 (0.958) 20.021 (0.874) 20.150 (0.276) 0.265 (0.046) 0.176 (0.190) 0.159 (0.237) 20.437 (0.001)*
Facial 0.127 (0.436) 20.081 (0.621) 20.099 (0.543) 20.187 (0.159) 20.232 (0.080) 0.125 (0.348) 20.075 (0.584) 0.159 (0.239) 20.138 (0.307) 0.270 (0.042) 20.096 (0.478)
Total 20.036 (0.824) 0.143 (0.377) 20.279 (0.081) 20.018 (0.894) 20.220 (0.097) 20.005 (0.970) 20.174 (0.205) 0.231 (0.083) 0.100 (0.457) 0.233 (0.081) 20.280 (0.035)
Abbreviations: MAC-S, Memory Assessment Clinics self-rating scale; MTL, medial temporal lobe; ICV, intracranial volume; RBANS, Repeatable Battery for the Assessment of Neuropsychological Status;
HP, hippocampus; ILV, inferior lateral ventricle; AMY, amygdala; IMI, Immediate Memory Index; DMI, Delayed Memory Index; Concen, Concentration; Emory WCST, Emory version of the Wisconsin Card
Sorting Test; #ID’d, number of sorting strategies initially identified; sorts, number of completed sorts; Persv, number of perseverative errors; Set Loss, number of set loss errors.
Bolded values 5 P  .05 (uncorrected).
*Correlations surviving the P  .025 false discovery rate correction threshold.
Table 4
Pearson correlations (P-value) between MAC-F scores, MTL volumes (in percent of total ICV), RBANS memory indices, and measures of executive functioning
MAC-S
Percent ICV (n 5 34) RBANS indices (n 5 51) Emory WCST (n 5 50)
HP ILV AMY IMI DMI Trails A Trails B # ID’d Sorts Persv Set loss
Ability to remember scales
Remote 0.278 (0.111) 20.093 (0.602) 0.484 (0.004)* 0.060 (0.677) 0.241 (0.088) 20.123 (0.390) 20.236 (0.106) 20.083 (0.566) 20.053 (0.715) 0.021 (0.885) 20.067 (0.644)
Numeric 0.439 (0.009)* 20.294 (0.092) 0.532 (0.001)* 0.135 (0.345) 0.250 (0.077) 0.033 (0.816) 20.044 (0.767) 20.034 (0.815) 0.093 (0.519) 20.016 (0.915) 20.189 (0.190)
Everyday 0.293 (0.093) 20.161 (0.362) 0.406 (0.017)* 20.011 (0.938) 0.094 (0.513) 20.030 (0.836) 0.004 (0.980) 0.117 (0.417) 0.061 (0.672) 0.012 (0.937) 20.186 (0.197)
Semantic 0.376 (0.114) 20.098 (0.583) 0.356 (0.039) 0.216 (0.127) 0.313 (0.025) 0.234 (0.099) 0.027 (0.855) 0.054 (0.710) 0.035 (0.810) 0.093 (0.519) 20.196 (0.173)
Spatial 0.338 (0.051) 20.178 (0.315) 0.386 (0.024)* 0.033 (0.817) 0.379 (0.006)* 0.121 (0.399) 0.087 (0.558) 20.225 (0.117) 20.191 (0.185) 0.150 (0.300) 20.010 (0.947)
Total 0.377 (0.028) 20.192 (0.276) 0.507 (0.002)* 0.100 (0.486) 0.327 (0.019)* 0.028 (0.846) 20.051 (0.733) 20.076 (0.601) 20.039 (0.790) 0.081 (0.577) 20.126 (0.382)
Frequency of occurrence scales
Semantic 0.251 (0.153) 20.161 (0.362) 0.388 (0.023)* 0.081 (0.571) 20.071 (0.618) 20.009 (0.950) 20.018 (0.904) 0.020 (0.890) 0.060 (0.678) 20.022 (0.877) 20.081 (0.578)
Concentration 0.260 (0.137) 20.167 (0.344) 0.223 (0.205) 0.105 (0.462) 0.133 (0.351) 0.188 (0.186) 0.138 (0.349) 0.007 (0.959) 20.050 (0.731) 0.229 (0.110) 20.138 (0.340)
Everyday 0.363 (0.035) 20.238 (0.175) 0.323 (0.062) 20.021 (0.885) 0.250 (0.077) 0.047 (0.742) 20.069 (0.643) 20.254 (0.075) 20.125 (0.387) 0.186 (0.197) 0.031 (0.829)
Forgetful 20.014 (0.937) 0.106 (0.550) 20.116 (0.514) 20.001 (0.993) 0.085 (0.553) 0.024 (0.868) 20.156 (0.288) 0.089 (0.540) 20.159 (0.269) 0.201 (0.162) 20.075 (0.604)
Facial 0.380 (0.027) 20.203 (0.249) 0.471 (0.005)* 20.096 (0.503) 0.102 (0.478) 0.046 (0.748) 20.040 (0.786) 20.139 (0.337) 20.217 (0.130) 0.182 (0.206) 0.079 (0.584)
Total 0.334 (0.053) 20.196 (0.267) 0.336 (0.052) 0.032 (0.823) 0.119 (0.406) 0.087 (0.543) 20.027 (0.856) 20.066 (0.647) 20.094 (0.518) 0.183 (0.203) 20.059 (0.685)
Abbreviations: MAC-F, Memory Assessment Clinics family-rating scale; HP, hippocampus; ILV, inferior lateral ventricle; AMY, amygdala; IMI, Immediate Memory Index; DMI, Delayed Memory Index;
MTL, medial temporal lobe; ICV, intracranial volume; RBANS, Repeatable Battery for the Assessment of Neuropsychological Status; Concen, Concentration; Emory WCST, Emory version of the Wisconsin
Card Sorting Test; #ID’d, number of sorting strategies initially identified; sorts, number of completed sorts; Persv, number of perseverative errors; Set Loss, number of set loss errors.
*Correlations surviving the P  .025 false discovery rate correction threshold.
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dementia) [also see 12].
Our data suggest that the previously noted limitations of
self-report data can be overcome by using an informant. Spe-
cifically, we found that the Semantic, Spatial, and Total
Ability scales of the MAC-F were related to patients’ perfor-
mance on the Delayed Memory Index of the RBANS. Infor-
mants also tended to rate everyday memory abilities as more
impaired compared with patients. These findings add to
recent reports that informant-based ratings are more closely
related to objective memory test performance [10] and
more sensitive to future decline [27] in those with MCI
when compared with self-report. A unique aspect of our
study was the inclusion of volumetric data, which revealed
robust and positive relationships between multiple MAC-F
scales and the volume of patients’ amygdala and, to a lesser
extent, hippocampus (see Tables 3 and 4). Thus, informant
report appears to be sensitive to both patients’ objective
memory test performance and the integrity of MTL
structures that are disproportionately affected in MCI and
AD. It is interesting to note that these relationships were
primarily limited to the Ability Scales and that they were
completely unrelated to measures of executive functioning.
Thus, informants may be more sensitive to actual memory
abilities (i.e., the correct vs. incorrect recall of information)
whereas patients focus on the frequency of memory lapses,
which reflects executive dysfunction. This may be an
important distinction that could explain some of the
variability in the existing literature and also meaningfully
shape future clinical and research efforts.
Overall, these results support current literature suggest-
ing a shift in the utility of subjective measures as a function
of disease severity. At an early stage, cognitively intact indi-
viduals who voice persistent concerns about memory (or
cognitive) impairment may be at increased risk of subse-
quent decline [6,28]. The previous findings suggest that
questions from the Semantic ability and several of the
Frequency scales may be especially promising for early
identification purposes but only as it relates to executive
functioning. Once cognitively symptomatic, however, the
evidence supports greater emphasis on informant-report
because it is more predictive of objective performance [10]
and subsequent conversion [6]. As alluded to previously,
a major limitation in this line of research has been in the
definition of, and measures used to assess, subjective
complaints. Recent efforts from international work groups
are helping to address these issues and hold promise for
clarifying the role of such complaints in both research and
clinical settings [29].
A considerable gap remains in the use of subjective
complaints for treatment planning purposes. For example,
patients who retain more insight are likely to be more
amenable to cognitive rehabilitation (or other interventions)
because they would recognize the need for assistance and be
motivated to actively engage in treatment. This is consonant
with our previous report that specific rehabilitativeapproaches (e.g., mnemonic strategy training) are more
appropriate for those with “early” MCI, whereas other
approaches may be best for “late”MCI [30]. Likewise, infor-
mants who recognize memory changes may be more willing
to facilitate or even engage in treatments, especially those
with the promise of enhancing patient independence and
reducing caregiver burden [31]. Such findings reiterate and
extend our call for the consideration of disease severity in
treatment planning [32].
Overall then, future diagnostic efforts should give
informant-report of memory impairment greater weight
than self-report when measuring memory abilities (i.e., the
correct vs. incorrect recall of information) whereas focusing
on the frequency of memory lapses may be a better reflection
of executive deficits in patients themselves. However, addi-
tional work is needed to clarify the role that both types of
information play in treatment planning.
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1. Systematic review: We reviewed literature, identified
viaPubMedand ISIWebofScience, about the relation-
ship between subjective memory complaints (self- and
informant-based), objectivememory test performance,
and medial temporal lobe (MTL) volumes in patients
with mild cognitive impairment (MCI).
2. Interpretation: Our results show that self-reported
subjective memory impairment is generally unre-
lated to objective memory performance or MTL
volumes; however, the frequency of memory lapses
was related to measures of executive functioning.
Conversely, informant-reported memory impairment
is reflective of both objective memory performance
and MTL volumes. Together, results suggest that
informant-report is more useful for verifying mem-
ory deficits whereas self-report may reflect executive
dysfunction.
3. Future directions: The point at which informant-
reported memory complaints should take prece-
dence over self-report needs to be identified.
Furthermore, additional work is needed in examining
the relationship between subjective memory
complaints and the efficacy of cognitively focused
interventions.
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